StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$370.78+2.54 (+0.69%)

Close on Nov 18, 2026Market cap $30.11BP/E 30.4Yield 0.78%

Labcorp operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Labcorp's operating cash flow for the twelve months ending Sep 30, 2026 was $1.82B, up 0.6% year over year. For fiscal 2025 it was $1.64B, up 3.4% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $3.11B in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.64B+3.4%
FY2024Dec 31, 2024$1.59B+19.4%
FY2023Dec 31, 2023$1.33B-32.1%
FY2022Dec 31, 2022$1.96B-37.1%
FY2021Dec 31, 2021$3.11B+45.6%
FY2020Dec 31, 2020$2.14B+47.8%
FY2019Dec 31, 2019$1.44B+10.7%
FY2018Dec 31, 2018$1.31B-12.9%
FY2017Dec 31, 2017$1.50B+25.1%
FY2016Dec 31, 2016$1.20B+21.9%
FY2015Dec 31, 2015$982.40M+32.9%
FY2014Dec 31, 2014$739.00M-9.7%
FY2013Dec 31, 2013$818.70M-2.7%
FY2012Dec 31, 2012$841.40M-1.7%
FY2011Dec 31, 2011$855.60M-3.2%
FY2010Dec 31, 2010$883.60M+2.5%
FY2009Dec 31, 2009$862.40M+10.4%
FY2008Dec 31, 2008$780.90M+10.0%
FY2007Dec 31, 2007$709.70M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$563.80M+45.6%
Q2 FY2026Jun 30, 2026$445.50M-28.2%
Q1 FY2026Mar 31, 2026$191.50M+935.1%
Q4 FY2025Dec 31, 2025$614.20M-21.0%
Q3 FY2025Sep 30, 2025$387.20M+39.6%
Q2 FY2025Jun 30, 2025$620.60M+10.6%
Q1 FY2025Mar 31, 2025$18.50M–
Q4 FY2024Dec 31, 2024$777.20M+34.1%
Q3 FY2024Sep 30, 2024$277.30M+0.7%
Q2 FY2024Jun 30, 2024$561.10M+59.7%
Q1 FY2024Mar 31, 2024-$29.80M-124.6%
Q4 FY2023Dec 31, 2023$579.60M-11.3%
Q3 FY2023Sep 30, 2023$275.50M-26.3%
Q2 FY2023Jun 30, 2023$351.40M-38.6%
Q1 FY2023Mar 31, 2023$121.20M-66.0%
Q4 FY2022Dec 31, 2022$653.60M-6.3%
Q3 FY2022Sep 30, 2022$373.80M-51.3%
Q2 FY2022Jun 30, 2022$572.50M+17.5%
Q1 FY2022Mar 31, 2022$356.00M-69.2%
Q4 FY2021Dec 31, 2021$697.50M-10.0%
Q3 FY2021Sep 30, 2021$767.30M-2.4%
Q2 FY2021Jun 30, 2021$487.20M+31.4%
Q1 FY2021Mar 31, 2021$1.16B+468.0%
Q4 FY2020Dec 31, 2020$774.60M+35.9%
Q3 FY2020Sep 30, 2020$786.20M+72.6%
Q2 FY2020Jun 30, 2020$370.70M+46.2%
Q1 FY2020Mar 31, 2020$203.80M+22.9%
Q4 FY2019Dec 31, 2019$569.80M+17.1%
Q3 FY2019Sep 30, 2019$455.60M+80.9%
Q2 FY2019Jun 30, 2019$253.50M-34.6%
Q1 FY2019Mar 31, 2019$165.80M-7.7%
Q4 FY2018Dec 31, 2018$486.40M-13.9%
Q3 FY2018Sep 30, 2018$251.90M-36.5%
Q2 FY2018Jun 30, 2018$387.40M+24.8%
Q1 FY2018Mar 31, 2018$179.70M-20.5%
Q4 FY2017Dec 31, 2017$565.00M+20.2%
Q3 FY2017Sep 30, 2017$396.70M–
Q2 FY2017Jun 30, 2017$310.50M–
Q1 FY2017Mar 31, 2017$225.90M–
Q4 FY2016Dec 31, 2016$470.10M–

More Labcorp figures

See a number that looks wrong?